期刊文献+

不同频率机采血小板对献血者血小板生成素的影响 被引量:5

The influence on the TPO from platelets collected from donors at different frquency
下载PDF
导出
摘要 目的了解不同频率机采血小板对献血者血小板生成素的影响。方法随机分别选取连续多次半个月、1个月和3个月捐献1次机采血小板的献血者,对其机采前的血小板生成素(TPO)、血小板(PLT)、平均血小板体积(MPV)进行统计分析。结果连续多次半个月机采1次血小板献血者的PLT升高、MPV和TPO下降,第2、3、4、5次采集与第1次相比差异有统计学意义(P<0.01);连续1个月机采1次血小板献血者的TPO下降,第2次采集与第1次相比差异有统计学意义(P<0.05),从第3次机采开始TPO下降(P<0.01),而PLT和MPV无明显变化(P>0.05);连续3个月机采1次血小板献血者的PLT、MPV和TPO与第1次相比皆无明显变化(P>0.05)。结论不同频率机采血小板对献血者的PLT、MPV和TPO的影响不同;1个月和3个月机采1次血小板是相对安全的,能缓解目前血小板短缺的状况。 Objective To Investigate the influence on TPO of platelets collected at different frequency of blood donation.Methods the TPO, Plt and MPV of donors before platelet donating are determined and analyzed in randomly selecting donors who donate platelet consecutively 15, 30, 90 day once. Result Compared with the first time, the second, third, fourth time's Plt was elevated and MPV, TPO are declined from consecutive 15 day in platelet donors(P〈0.01). In the consecutive 30 day once platelet donors, the TPO was declined(the second time compared with the first time P〈0.05 and beginning from the third time P〈0.01), but there is no difference between Plt and MPV(P〉0.05).There is no difference between Plt, MPV and TPO from consecutive 90 day once platelet donors(P〉0.05). Conclusion The influence is different for Plt, MPV and TPO between different frequency of platelet donation. It is relatively safe from consecutive 30, 90 day once for donating platelets, Plt deficit could be hence avoided.
出处 《广东医学院学报》 2015年第1期72-74,共3页 Journal of Guangdong Medical College
基金 湛江市非资助科技攻关计划项目(No.2014B01136)
关键词 机采血小板 献血者 血小板生成素 platelet donating blood donor TPO
  • 相关文献

参考文献7

二级参考文献52

共引文献48

同被引文献38

  • 1戴宇东,孙启俊,孟钵,徐树良.频繁单采血小板影响献血员巨核细胞的生成[J].中国实验血液学杂志,2005,13(2):320-322. 被引量:7
  • 2Begley CG, Basser RL. Biologic and structural differences of throm- bopoietic growth factors. Semin FIematol, 2000, 37 (2 Suppl 4 ) : 19-27.
  • 3Alexander WS. Thrombopoietin and the c-mpl receptor: insights from gene targeting. Inter J Bio, 1999,31 (9) : 1027-1030.
  • 4Murone M, Carpenter DA, de Sauvage DF, et al. Hematopoietic de- ficiencies in c-mpl and TPO Knockout mice. Stem Cells, 1998,16(1):1-4.
  • 5Bunting S, Widmer R, Lipari T, et al. Normal platelets and megakaryocytes are produced in vivo in he absence of thmmbopoie- tin. Blood,1997,90(13) :3423-3427.
  • 6Gainsford T, Roberts AW, Kimuras A, et al. Cytokine production and function in c-mpl-deficient mice:no physiological role for inter- leakin-3 in residual megakaryocyte and platele production. Blood, 1998,91 (20) :2745-2747.
  • 7Yang M, Chesterman CN, Chong BH. Recombinant PDGF en- hances megakaryocytopoiesis in vitro. Br J Haematol, 1995, 91 (2) : 285-289.
  • 8Su R J, Li K, Yang M, et al. platelet- derived growth factor enhance- ex vivo expansion of megakaryocytic progenitors from human cord blood. Bone Marrow Transplant, 2001,27(10) :1075-1080.
  • 9Taeke F, Schoffski P, Tautwein C, et al. Endogenous serum levels of thrombopoietic cytokines in healthy whole-bolld and platelet do- nors :implications plateletpheresis. Br J Haematol, 1999,105 (4) : 511-513.
  • 10周敏,杨默.血小板生成素相关分子研究进展[J].实用儿科临床杂志,2009,24(15):1141-1144. 被引量:6

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部